02591.HK
Guangzhou Innogen Pharmaceutl Grp Co Ltd
HKSE · Healthcare · Biotechnology · CN
HKD 3.60
−0.14%Aug 25, 2026, 10:11 UTC
Yinuo Medical (B) announced its interim results for the six months ended June 2026, with revenue up 38.6% year-on-year and net loss narrowing to RMB 115 million.
Source:Aug 24, 2026, 03:35 UTC
Silverno Pharma announced it has built an internal AI-driven drug discovery closed loop using proprietary wet-lab data, producing novel large and small molecule entities advancing toward preclinical validation.
Source: